Literature DB >> 2527826

Penetration of norfloxacin into abdominal wall muscle tissue.

M Dan, F Serour, A Gorea, M Krispin, S A Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2527826     DOI： 10.1007/bf01639531

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  3 in total

Review 1.  Norfloxacin: a new targeted fluoroquinolone antimicrobial agent.

Authors:  J S Wolfson; D C Hooper
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

2.  Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.

Authors:  J E Karp; W G Merz; C Hendricksen; B Laughon; T Redden; B J Bamberger; J G Bartlett; R Saral; P J Burke
Journal:  Ann Intern Med       Date:  1987-01       Impact factor: 25.391

3.  In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.

Authors:  B A Body; R A Fromtling; S Shadomy; H J Shadomy
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.